Global health insurance service company
Discuss issues related to legislation to repeal a 40 percent ACA excise tax on certain employer-sponsored health insurance plans; S. 172 / H.R. 1398, the Health Insurance Tax (HIT) Relief Act of 2019 (legislation to suspend the ACA's health insurance tax (HIT) in 2020 and 2021); and S.80, Jobs and Premium Protection Act (full repeal of the HIT). Discuss issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, and non-discrimination provisions; and S. 1895, the Lower Health Care Costs Act. Discuss issues related to ongoing implementation of payment and regulatory issues for the Medicare Advantage program; drug pricing legislation, including H.R. 3, the Lower Drug Costs Now Act of 2019, and S. 2543, the Prescription Drug Pricing Reduction Act of 2019; proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap, and direct negotiation of prescription drug prices.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
INVARIANT LLC
740 15th St NW, Floor 5, Washington, DC, 20005, US
BENJAMIN KLEIN KATHRYN WISE BENJAMIN KLEIN KATHRYN WISE BENJAMIN KLEIN KATHRYN WISE